Study of NGM120 in Subjects With Advanced Solid Tumors and Pancreatic Cancer Using Combination Therapy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04068896 |
|
Recruitment Status :
Recruiting
First Posted : August 28, 2019
Last Update Posted : May 24, 2021
|
Sponsor:
NGM Biopharmaceuticals, Inc
Information provided by (Responsible Party):
NGM Biopharmaceuticals, Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 2023 |
| Estimated Study Completion Date : | November 2023 |